Pexmetinib

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePexmetinib
Drug Alias NamepexmetinibumpexmetinibARRY-614
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTEK receptor tyrosine kinase antagonistsP38 γ mitogen-activated protein kinase inhibitors
TargetsP38 γ mitogen-activated protein kinaseTEK receptor tyrosine kinase
Therapy Area/IndicationsMyelodysplastic Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesArray Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArray Biopharma Inc
Active IndicationsN/A
Inactive IndicationsMyelodysplastic Syndromes

Other Information

ATC CodeN/A
Related LinksN/A